EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeit

Inflammatory Markers and Contrast‐Induced Nephropathy Risk: A Meta‐Analysis of NLR and PLR in ACS Patients Undergoing Percutaneous Coronary Intervention

Hashim M AlHammouri iD, Osama Mustafa iD, Nour Mash'al iD, Siya Suwan, Mohammad Al-Rababa'h, Ahmad Z Turk, Ahmad Toubasi

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70056 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Hashim M AlHammouri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Jordan, Amman, Jordan. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Contrast Media, Coronary Angiography, Inflammation Mediators. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Contrast‐induced nephropathy (CIN) is a serious complication after percutaneous coronary intervention (PCI), especially in acute coronary syndrome (ACS) patients. While risk factors are known, predicting CIN remains difficult. New biomarkers like the neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio (PLR) are gaining attention as potential predictors due to their links with inflammation and coagulation.

Aims

This meta‐analysis examines whether NLR and PLR can predict CIN risk in PCI patients with ACS, aiming to clarify their diagnostic value.

Methods

We analyzed data from 25 studies with 25,505 patients, looking at the link between preprocedural NLR and PLR and CIN risk. We calculated odds ratios (OR), sensitivity, specificity, and area under the curve (AUC) values to assess diagnostic accuracy.

Results

A total of 25,505 patients from 25 studies were included. Elevated preprocedural NLR and PLR were significantly associated with increased CIN risk. In the ACS population, 15 studies demonstrated that NLR was significantly associated with increased odds of CIN, with a pooled OR of 1.21 (95% confidence interval (CI): 1.12 to 1.30, p < 0.001). Receiver operating characteristic analysis showed moderate sensitivity (72%), specificity (60%), and an AUC of 71%. Similar trends were observed in ST‐segment elevation myocardial infarction (STEMI). The non‐STEMI (NSTEMI) subgroup showed a stronger association, with a pooled OR of 2.03 (95% CI: 1.13 to 3.65, p = 0.02), moderate to good diagnostic accuracy (AUC 79%), and higher sensitivity (77%) and specificity (73%). For PLR, significant associations with CIN were found in the ACS population (OR: 1.16, 95% CI: 1.04 to 1.30, p = 0.007), with moderate diagnostic accuracy (AUC: 0.67, 95% CI: 0.61 to 0.73). In the STEMI population, PLR was also significantly associated with CIN (OR: 1.34, 95% CI: 1.14 to 1.57, p < 0.001), but diagnostic accuracy was lower (AUC: 0.66, 95% CI: 0.59 to 0.74). Limited data from the NSTEMI population showed a moderate association (AUC: 0.68, 95% CI: 0.64 to 0.72), indicating fair diagnostic accuracy.

Conclusion

Preprocedural NLR and PLR are simple, cost‐effective biomarkers for predicting CIN risk in ACS, especially among NSTEMI patients undergoing PCI. These markers can facilitate earlier identification of high‐risk patients and enable targeted preventive strategies. However, their moderate diagnostic performance highlights the need for the development of more specific and sensitive biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeContrast MediaCoronary AngiographyInflammation MediatorsKidney DiseasesPercutaneous Coronary InterventionAgedFemaleHumansMaleMiddle AgedArea Under CurveBiomarkersBlood PlateletsLymphocyte CountLymphocytesNeutrophilsOdds RatioPlatelet CountPredictive Value of TestsRisk AssessmentRisk FactorsTreatment Outcome

Stichwörter der Autor:innen

acute coronary syndromebiomarkerscontrast‐induced nephropathyinflammationneutrophil‐to‐lymphocyte ratiopercutaneous coronary interventionplatelet‐to‐lymphocyte ratio

Substanzen

BiomarkersContrast MediaInflammation Mediators

Autor:innen und Institutionen

  • Faculty of Medicine, University of Jordan, Amman, Jordan.
  • Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Saint Luke's Hospital, University of Missouri-Kansas City, Kansas City, Missouri, USA.
  • Department of Neurology, Neuroimaging Unit, Neuroimmunology Devision, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Hashim M AlHammouri, Osama Mustafa, Nour Mash'al

Zitieren

APA

AlHammouri, H. M., Mustafa, O., Mash'al, N., Suwan, S., Al-Rababa'h, M., Turk, A. Z., & Toubasi, A. (2025). Inflammatory Markers and Contrast‐Induced Nephropathy Risk: A Meta‐Analysis of NLR and PLR in ACS Patients Undergoing Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70056

Vancouver

AlHammouri HM, Mustafa O, Mash'al N, Suwan S, Al-Rababa'h M, Turk AZ, et al. Inflammatory Markers and Contrast‐Induced Nephropathy Risk: A Meta‐Analysis of NLR and PLR in ACS Patients Undergoing Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70056

BibTeX
@article{AlHammouri2025,
  author = {AlHammouri, Hashim M and Mustafa, Osama and Mash'al, Nour and Suwan, Siya and Al-Rababa'h, Mohammad and Turk, Ahmad Z and Toubasi, Ahmad},
  title = {Inflammatory Markers and Contrast‐Induced Nephropathy Risk: A Meta‐Analysis of NLR and PLR in ACS Patients Undergoing Percutaneous Coronary Intervention},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70056}
}
Kostenlos starten →